Category Archives: – Biotech

Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market

The transcript is found here May 19, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, CDC, Congress, FDA, Genetics, Infectious disease, NIH, Oncology | 9 Comments

The U.S. Military’s Moderna Division Rams Through Another Untested mRNA Gene Therapy

June 1, 2024- by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, CDC, Congress, FDA, Infectious disease, NIH | Leave a comment

Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies

July 12, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology | Leave a comment

Florida becomes the first state to recommend against getting the gene therapy “vaccines” for COVID

October 9, 2022- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Harvard, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine | Leave a comment

mRNA vaccine boosters and impaired immune system response

February 3, 2024- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, CDC, Congress, FDA, Infectious disease | Leave a comment

Any type of coronavirus vaccine (i.e., gene therapy) that uses the spike-protein will be deadly

February 20, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, FDA | Leave a comment

Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham

July 7, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment

Steven E. Greer, MD on OANN discussing virus therapies

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment

Did the COVID vaccines change the human genome?

May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

May 22, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment

COVID mRNA gene therapies never worked and are now clearly harmful

November 5, 2021- by Steven E. Greer, MD In the most prestigious journal in all of science, Science magazine posted this article. The authors studied vaccine efficacy over time in VA patients. The effectiveness at preventing COVID infections fell to … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy | Leave a comment

CRISPR is the biggest threat to mankind

June 23, 2021- by Steven E. Greer Today, I received my media embargo copy of a New England Journal of Medicine article on genetic engineering

Posted in - Biotech, - Opinion, - Policy, Congress, FDA, Genetics, NIH | Leave a comment

Are the so-called mRNA vaccines actually nano-particles?

Diagram from “Speeding COVID-19 Drug Discovery with Quantum Dots”, Posted on November 5th, 2020 by Dr. Francis Collins March 16, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Pharma, CDC, FDA, Infectious disease | Leave a comment

New York Times: Booster shots cause immune system fatigue

December 30, 2021- by Steven E. Greer, MD Einstein’s definition of insanity, to paraphrase, is doing the same thing over and over and expecting different results.

Posted in - Biotech, - NEJM, - Opinion, - Pharma | Leave a comment

How to beat the virus with early treatment

July 22, 2021- by Steven E. Greer, MD I woke up yesterday with a slight malaise and I sneezed once. I knew I had come down with a virus

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Duke, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | Leave a comment